Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,107 | -51,955 | -38,355 | -25,348 | -13,036 |
| Depreciation Amortization | -729 | -712 | -106 | 19 | 20 |
| Accounts payable and accrued liabilities | 3,398 | 518 | 2,838 | 1,726 | 1,251 |
| Other Working Capital | 5,213 | 959 | 3,646 | 2,409 | 3,154 |
| Other Operating Activity | -1,823 | 3,828 | 228 | 239 | -388 |
| Operating Cash Flow | $-9,048 | $-47,362 | $-31,749 | $-20,955 | $-8,999 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18,679 | -57,496 | -30,829 | 14,578 | 5,471 |
| PPE Investments | -172 | -346 | -96 | -68 | -44 |
| Investing Cash Flow | $18,507 | $-57,842 | $-30,925 | $14,510 | $5,427 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,009 | 471 | 146 | 49 | 6 |
| Financing Cash Flow | $1,009 | $471 | $146 | $49 | $6 |
| Beginning Cash Position | 19,927 | 124,660 | 124,660 | 124,660 | 124,660 |
| End Cash Position | 30,395 | 19,927 | 62,132 | 118,264 | 121,094 |
| Net Cash Flow | $10,468 | $-104,733 | $-62,528 | $-6,396 | $-3,566 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,048 | -47,362 | -31,749 | -20,955 | -8,999 |
| Capital Expenditure | -172 | -346 | -96 | -68 | -44 |
| Free Cash Flow | -9,220 | -47,708 | -31,845 | -21,023 | -9,043 |